STOCK TITAN

Exicure HiTron trims Exicure (NASDAQ: XCUR) stake, remains 40.7% holder

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Exicure HiTron Inc., a major shareholder of Exicure, Inc., has amended its beneficial ownership report after selling part of its stake. On January 7, 2026, Exicure HiTron completed share transfer agreements covering 741,272 common shares at $4.50 per share, for total proceeds of $3,335,724. The shares were sold for liquidity purposes to three individuals: Im Sung Jin, Lee Aram, and Im Bumjin.

After giving effect to these transfers, Exicure HiTron reports beneficial ownership of 2,592,061 Exicure common shares, representing about 40.7% of the 6,373,869 shares outstanding as of November 3, 2025. Exicure HiTron retains sole voting and dispositive power over these remaining shares.

Positive

  • None.

Negative

  • None.

Insights

Large holder trims position for liquidity but remains a 40.7% owner.

Exicure HiTron Inc. completed a sale of 741,272 Exicure common shares at $4.50 per share for total proceeds of $3,335,724. The filing states the transfers were made for liquidity purposes, with shares going to three named individual transferees under share transfer agreements dated December 30, 2025.

Following these transactions, Exicure HiTron still beneficially owns 2,592,061 shares, or about 40.7% of the 6,373,869 shares outstanding as of November 3, 2025, with sole voting and dispositive power. This indicates a reduced but still very significant influence on shareholder votes and corporate governance.

The amendment formalizes this change in ownership structure as of January 7, 2026. Future company disclosures may provide additional context on any strategic implications of the shift from a larger to a smaller, but still controlling, stake.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D


Exicure HiTron Inc.
Signature:/s/ Young Chul Han
Name/Title:CEO
Date:01/08/2026

FAQ

What change in ownership did Exicure HiTron report in this XCUR Schedule 13D/A?

Exicure HiTron reported that it transferred 741,272 Exicure common shares at $4.50 per share, reducing its holdings but remaining a major shareholder.

How many Exicure (XCUR) shares does Exicure HiTron own after the share transfers?

After the transfers, Exicure HiTron beneficially owns 2,592,061 Exicure common shares, with sole voting and dispositive power over these shares.

What percentage of Exicure (XCUR) does Exicure HiTron own following this amendment?

Exicure HiTron reports ownership of approximately 40.7% of Exicure's common stock, based on 6,373,869 shares outstanding as of November 3, 2025.

For what reason did Exicure HiTron sell 741,272 Exicure (XCUR) shares?

The filing states that the 741,272 shares were transferred "for liquidity purposes" under share transfer agreements.

Who purchased the Exicure (XCUR) shares sold by Exicure HiTron and for how much?

The transferees were Im Sung Jin (248,028 shares, $1,116,126), Lee Aram (234,882 shares, $1,056,969), and Im Bumjin (258,362 shares, $1,162,629).

What total proceeds did Exicure HiTron receive from selling Exicure (XCUR) shares?

Exicure HiTron received aggregate proceeds of $3,335,724 from transferring 741,272 shares at $4.50 per share.
Exicure Inc

NASDAQ:XCUR

XCUR Rankings

XCUR Latest News

XCUR Latest SEC Filings

XCUR Stock Data

39.84M
2.38M
63.15%
12.88%
0.48%
Biotechnology
Pharmaceutical Preparations
Link
United States
CHICAGO